Emerging Viral Diseases-Expert Laboratory Network (EVD-LabNet)

EVD-Labnet logo

Aim and scope of the network

EVD-LabNet is a multi-disciplinary network of expert laboratories. Its aim is to strengthen Europe’s laboratory capacity and capability to respond to emerging, re-emerging and vector-borne viral disease threats.

The network laboratories are located in the EU/EEA and EU candidate countries. These laboratories have a strong basic and/or translation research competence in virology and human (reference) diagnostics and/or experience in diagnostic test development for viral pathogens.

The network is not currently accepting additional members but expressions of interest can be sent to EVD-LabNet secretariat. A list of EVD-LabNet laboratories is available.

Although EVD-LabNet has a strong focus on public health, the network embraces a One Health approach and has established strong links with the animal health sector in particular. EVD-LabNet also has connections to other European emerging infectious disease preparedness and response networks and activities.

EVD-LabNet directory

    Target viruses

    The network covers viruses significant to public health from the following genera (families):

    • Alphavirus (Togaviridae)
    • Coltivirus (Reoviridae)
    • Ebolavirus (Filoviridae)
    • Flavivirus (Flaviviridae)
    • Henipavirus (Paramyxoviridae)
    • Lyssavirus (Rhabdoviridae)
    • Mammarenavirus (Arenaviridae)
    • Marburgvirus (Filoviridae)
    • Orbivirus (Reoviridae)
    • Orthobornavirus (Bornaviridae)
    • Orthobunyavirus (Peribunyaviridae)
    • Orthohantavirus (Hantaviridae)
    • Orthonairovirus (Nairoviridae)
    • Orthorubulavirus (Paramyxoviridae)
    • Orthopoxvirus (Poxviridae)
    • Parapoxvirus (Poxviridae)
    • Phlebovirus (Phenuiviridae)
    • Thogotovirus (Orthomyxoviridae)
    • Respirovirus (Paramyxoviridae)
    • Vesiculovirus (Rhabdoviridae).

    Objectives

    EVD-LabNet supports clinical diagnostics, surveillance, threat assessments and outbreak preparedness and response by providing essential background information on target viruses, with a focus on:

    • scientific expertise concerning the viruses, their make-up, pathogenesis, physicochemical properties, and patient- and population-oriented detection/ruling out of infection;
    • (reference) diagnostics;
    • state-of-the-art European diagnostic portfolio, diagnostic capacity and capability;
    • molecular detection and characterisation support for response and surveillance activities;
    • training courses, workshops and webinars for virologists (selected training/webinars will be open to public health epidemiologists);
    • twinning activities (transnational education);
    • annual meetings to strengthen the coherence of the network and provide a platform to exchange knowledge

    Most activities are restricted to network members but some will be open to non-network members. Check the list of activities below and register for the newsletter to be informed.

    Ongoing activities

    External quality assessments (EQAs)

    Two external quality assessments were conducted in 2022: on rodent-borne viruses and emerging alphaviruses. Results of the EQA will be communicated in due time.

    Training courses and webinars

    The network has organised webinars and trainings on

    • emerging alphaviruses – 30 May 2022
    • rodent-borne diseases – 27 June 2022
    • tick-borne encephalitis in Europe – 28 September 2022 (see the presentations)

    Annual network meeting

    The fifth annual network meeting was held on 23−24 June 2021 (online). The next annual network meeting will take place during early 2023.

    Scientific support

    Two factsheets have recently been published on ECDC website:

      Newsletter

      Governance

      EVD-LabNet is coordinated by Dr Chantal Reusken from the Dutch National Institute for Public Health and the Environment (RIVM).

      EVD-LabNet Management Team

      The management team is responsible for the design and implementation of activities. The management team is composed of:

      • Dr Chantal Reusken from RIVM (the Netherlands)
      • Prof. Rémi Charrel from the University of Aix-Marseille (France, deputy coordinator)
      • Dr Luisa Barzon from the University of Padova (Italy)
      • Prof. Marion Koopmans from Erasmus MC (the Netherlands)
      • Prof. Anna Papa from the Aristotle University of Thessaloniki (Greece)
      • Prof. Olli Vapalahti from the University of Helsinki (Finland)
      • Dr Tamas Bakonyi from ECDC
      • Dr Céline Gossner from ECDC.

      EVD-LabNet Scientific Advisory Board

      The Scientific Advisory Board advises the management team on scientific aspects of the network activities. The board consists of the following representatives:

      • Dr Chantal Reusken from RIVM (the Netherlands)
      • Prof. Roger Hewson from London School of Hygiene & Tropical Medicine (United Kingdom)
      • Dr Yaniv Lustig from the National Center for Zoonotic Viruses (Israel)
      • Prof. Bruno Coutard from the University of Aix-Marseille (France)
      • Dr Antonino Di Caro from the National Institute for Infectious Diseases “L. Spallanzani”, Sacro Cuore Don Calabria Hospital and Unicamillus International Medical University of Rome (Italy)
      • Prof. Martin Groschup from the Friedrich-Loeffler-Institut (Germany)
      • Dr Stephan Zientara from the Agency for Food, Environmental and Occupational Health & Safety (France)
      • Dr Harold Noël from Santé publique France (France)
      • Dr Shaman Muradrasoli from the Public Health Agency (Sweden)
      • Dr Cinthia Menel Lemos from the European Commission
      • Dr Joanna Zwetyenga from the World Health Organization’s Regional Office for Europe
      • Dr Tamas Bakonyi from ECDC
      • Dr Céline Gossner from ECDC.

      More on the topic